Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release
- PMID: 6206153
Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release
Abstract
Proteolytic digestion of human lung tissue dispersed a population of cells (HDLC) containing 1 to 8% mast cells but which were free from bronchial and vascular smooth muscle. Incubation of HDLC with anti-human IgE, which released a net 24.8 + 4.3% of mast cell-derived histamine, stimulated a 14-fold increase in the generation of PGD2, a seven-fold increase in TXB2, and less than a twofold increase in PGF2 alpha, immunoreactive PGE, (i-PGE) and 6-keto-PGF1 alpha. A similar profile of prostanoid release was observed when cells were challenged with epsilon-specific anti-IgE, indicating that the response was specific to the coupling of IgE Fc receptors. The calcium ionophore A23187 also released prostanoids from HDLC in approximately the same proportions as anti-IgE. This stimulus, however, released only 50% as much PGD2 per nanogram histamine than did IgE-dependent activation, thereby showing a fundamental difference in the mechanisms by which the two agents activate mast cells and liberate arachidonic acid for oxidative metabolism. In concentration-response and time course experiments, both secretory stimuli released prostanoids and histamine in parallel. After separation of lung cells by isopyknic centrifugation, challenge with anti-IgE or A23187 released PGD2 only from those fractions containing mast cells, the amount released corresponding closely to both the mast cell concentration and net histamine release. On pooling data from all experiments, the closest correlation was found between release of PGD2 and histamine when cells were stimulated with either anti-IgE (r = 0.813, p less than 0.001) or A23187 (r = 0.763, p less than 0.001), supporting a mast cell origin for PGD2. The release of other prostanoids in fractions not containing mast cells demonstrates that macrophages, monocytes, and lymphocytes have the capacity to generate TXB2, PGF2 alpha, and i-PGE both in the absence and presence of mast cells. Thus, although mast cells are likely to be the major source of PGD2 generated upon IgE-dependent stimulation of HDLC, other cells dispersed from lung tissue have the capacity to generate prostanoids directly after activation of their IgE-Fc receptors and, indirectly after the secretion of mast cell mediators.
Similar articles
-
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.J Immunol. 1982 Oct;129(4):1627-31. J Immunol. 1982. PMID: 6809826
-
The generation of prostaglandins by human lung and their effects on airway function in man.Bull Eur Physiopathol Respir. 1986;22 Suppl 7:81-90. Bull Eur Physiopathol Respir. 1986. PMID: 3513876 Review.
-
Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.J Immunol. 1987 Jul 15;139(2):494-500. J Immunol. 1987. PMID: 2439587
-
Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.J Immunol. 1995 Mar 15;154(6):2855-65. J Immunol. 1995. PMID: 7533185
-
On the role of PGD2 metabolites as markers of mast cell activation in asthma.Acta Physiol Scand Suppl. 1999 Apr;644:1-74. Acta Physiol Scand Suppl. 1999. PMID: 10352758 Review.
Cited by
-
9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.J Clin Invest. 1987 Mar;79(3):978-83. doi: 10.1172/JCI112909. J Clin Invest. 1987. PMID: 3469218 Free PMC article.
-
Immunological and non-immunological release of leukotrienes and histamine from human nasal polyps.Clin Exp Immunol. 1986 Mar;63(3):711-7. Clin Exp Immunol. 1986. PMID: 2423281 Free PMC article.
-
The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.Br J Clin Pharmacol. 1988 Feb;25(2):157-63. doi: 10.1111/j.1365-2125.1988.tb03286.x. Br J Clin Pharmacol. 1988. PMID: 2451929 Free PMC article. Clinical Trial.
-
Overview of allergic mechanisms. Ebastine has more than an antihistamine effect.Drugs. 1996;52 Suppl 1:15-9. doi: 10.2165/00003495-199600521-00005. Drugs. 1996. PMID: 8983912 Clinical Trial.
-
COX-1 mediates IL-33-induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity.J Allergy Clin Immunol. 2019 Mar;143(3):1047-1057.e8. doi: 10.1016/j.jaci.2018.06.033. Epub 2018 Jul 12. J Allergy Clin Immunol. 2019. PMID: 30017554 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical